# 60 DEGREES PHARMACEUTICALS, INC. (SXTPW) — capital_raise/atm_program [expired]
Source: SEC API (secapi.ai) · situation sit_afc13ebeed3a705d5548 · retrieved 2026-08-12T06:58:45.053Z

## Overview
60 Degrees Pharmaceuticals, Inc. is a pharmaceutical company developing pharmaceutical products subject to FDA jurisdiction.

On July 30, 2026, 60 Degrees Pharmaceuticals entered into a Securities Purchase Agreement with institutional investors for a private placement offering. The company agreed to issue 191,571 shares of common stock at $1.74 per share, pre-funded warrants to purchase 383,142 shares at $1.739 per warrant, Series A warrants to purchase 574,413 shares, and Series B warrants to purchase 574,413 shares, all for gross proceeds of approximately $1.0 million before placement agent fees and offering expenses. The closing occurred on July 31, 2026. The Series A Warrants expire five years from the effective date of the registration statement, while Series B Warrants expire 24 months from the effective date. Pre-funded Warrants have an exercise price of $0.001 per share and are exercisable immediately upon issuance.

## Terms
- Counterparty: Institutional investors · Deal value: $1.0M · Consideration: mixed · Price/share: $1.74

## Key dates
- Expired 2026-08-04

## Timeline
- 2026-08-04 · 8-K (0001213900-26-085235): 8-K - 60 DEGREES PHARMACEUTICALS, INC. — *60 Degrees Pharmaceuticals, Inc. is a pharmaceutical company developing pharmaceutical products subject to FDA jurisdiction.* On July 30, 2026, 60 Degrees Pharmaceuticals entered into a Securities Purchase Agreement with institutional investors for a private placement offering. The company agreed to issue 191,571 shares of common stock at $1.74 per share, pre-funded warrants to purchase 383,142 shares at $1.739 per warrant, Series A warrants to purchase 574,413 shares, and Series B warrants to purchase 574,413 shares, all for gross proceeds of approximately $1.0 million before placement agent fees and offering expenses. The closing occurred on July 31, 2026. The Series A Warrants expire five years from the effective date of the registration statement, while Series B Warrants expire 24 months from the effective date. Pre-funded Warrants have an exercise price of $0.001 per share and are exercisable immediately upon issuance.
  https://www.sec.gov/Archives/edgar/data/1946563/0001213900-26-085235.txt

## Citations
- 0001213900-26-085235 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000121390026085235